Latest News Feed
Uploaded
11-10-2026
AHA 2026: Lp(a)FRONTIERS EXPANSION: Pelacarsen in ASCVD
AHA 2026: Lp(a)FRONTIERS EXPANSION: Pelacarsen in ASCVD What can Lp(a)FRONTIERS EXPANSION tell us about Lp(a) treatment i ...
Uploaded
11-10-2026
AHA 2026: TRANSFORM-HTN: Long-Term Lorundrostat in Hypertension
AHA 2026: TRANSFORM-HTN: Long-Term Lorundrostat in Hypertension TRANSFORM-HTN evaluates the long-term efficacy, safety an ...
Uploaded
11-10-2026
AHA 26: IRONMET-HFpEF: IV Iron and Exercise Capacity in HFpEF
AHA 26: IRONMET-HFpEF: IV Iron and Exercise Capacity in HFpEF IRONMET-HFpEF investigates whether intravenous iron repleti ...
Tweeted
11-10-2026
Radcliffe Cardiology
@radcliffeCARDIO What can one of cardiology’s oldest medicines teach us about individualised care? Reignier S Leigh and Dr Leigh C Reardon bring patient and clinician perspectives together in a striking exploration of digoxin, ACHD and lived experience. 🔗 https://t.co/ipCJjEnUdo doi.org/10.15420/usc.2…EnUdo #k9oLb
Radcliffe Cardiology
@radcliffeCARDIO What can one of cardiology’s oldest medicines teach us about individualised care? Reignier S Leigh and Dr Leigh C Reardon bring patient and clinician perspectives together in a striking exploration of digoxin, ACHD and lived experience. 🔗 https://t.co/ipCJjEnUdo doi.org/10.15420/usc.2…EnUdo #k9oLb
Tweeted
11-10-2026
Radcliffe Cardiology
@radcliffeCARDIO Are we underestimating aldosterone’s role in resistant hypertension? 🫀 @DrManishNSaxena examines what longer-term findings with aldosterone synthase inhibition add to the debate. More key evidence from AHA 2026 👉 https://t.co/wJz5Dl8GOR #AHA2026 #Hype🫀 @DrManishNSaxena examines what longer-term findings with aldosterone synthase inhibition add to the debate. More key evidence from AHA 20radc.life/lDRUdlloz5Dl8GOR #AHA2026 #HypermeYtwqKH
Radcliffe Cardiology
@radcliffeCARDIO Are we underestimating aldosterone’s role in resistant hypertension? 🫀 @DrManishNSaxena examines what longer-term findings with aldosterone synthase inhibition add to the debate. More key evidence from AHA 2026 👉 https://t.co/wJz5Dl8GOR #AHA2026 #Hype🫀 @DrManishNSaxena examines what longer-term findings with aldosterone synthase inhibition add to the debate. More key evidence from AHA 20radc.life/lDRUdlloz5Dl8GOR #AHA2026 #HypermeYtwqKH
Uploaded
11-10-2026
AHA 2026: TYDAL-TIMI 78: ANGPTL4 Inhibition With MAR001
AHA 2026: TYDAL-TIMI 78: ANGPTL4 Inhibition With MAR001 TYDAL-TIMI 78 investigates ANGPTL4 inhibition with MAR001 in adul ...
Tweeted
11-10-2026
Radcliffe Cardiology
@radcliffeCARDIO How can we better measure disease progression in ATTR-CM? 📊 📺 @WomenAs1 #CLIMB2026 presents Transthyretin Amyloidosis with Dr Esther Gonzalez Lopez! Watch Now 👉 🔎 Explore updated criteria for monitoring ATTR-CM 🫀 Distinguish amyloid deposition from disease progression 🧪 htt 📺 @WomenAs1 #CLIMB2026 presents Transthyretin Amyloidosis with Dr Esther Gonzalez Lopez! Watch Now 👉 🔎 Explore updated criteria for monitoring ATTR-CM 🫀 Distinguish amyloid deposition from disease ://t.co/t3IzvRuNwW
Radcliffe Cardiology
@radcliffeCARDIO How can we better measure disease progression in ATTR-CM? 📊 📺 @WomenAs1 #CLIMB2026 presents Transthyretin Amyloidosis with Dr Esther Gonzalez Lopez! Watch Now 👉 🔎 Explore updated criteria for monitoring ATTR-CM 🫀 Distinguish amyloid deposition from disease progression 🧪 htt 📺 @WomenAs1 #CLIMB2026 presents Transthyretin Amyloidosis with Dr Esther Gonzalez Lopez! Watch Now 👉 🔎 Explore updated criteria for monitoring ATTR-CM 🫀 Distinguish amyloid deposition from disease ://t.co/t3IzvRuNwW
Tweeted
11-10-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #USCJournal Article: "Finding Inspiration in an Old Cardiac Medication" 📚 Just Published! 🔓Access it here 👉 https://t.co/YE80cmpBUE ow.ly/YBbN106Icyyo/YE80cmpBUE @o/ypOZxpWLNl
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #USCJournal Article: "Finding Inspiration in an Old Cardiac Medication" 📚 Just Published! 🔓Access it here 👉 https://t.co/YE80cmpBUE ow.ly/YBbN106Icyyo/YE80cmpBUE @o/ypOZxpWLNl
Tweeted
11-10-2026
Radcliffe Cardiology
@radcliffeCARDIO 🔴 Expert-led #CardioOnc webinar happening TODAY titled 'Cardio-Oncology Survivorship Workshop: From Guidelines to Practice - MODULE 2 - During Treatment: Managing Toxicity Without Derailing Care'.radcliffecardiology.com/webinars/cardi…ajBotR ⏰ 12:30 GMT | 07:30 EST Don’t miss oux55WVDRRq6
Radcliffe Cardiology
@radcliffeCARDIO 🔴 Expert-led #CardioOnc webinar happening TODAY titled 'Cardio-Oncology Survivorship Workshop: From Guidelines to Practice - MODULE 2 - During Treatment: Managing Toxicity Without Derailing Care'.radcliffecardiology.com/webinars/cardi…ajBotR ⏰ 12:30 GMT | 07:30 EST Don’t miss oux55WVDRRq6
Tweeted
11-09-2026
Radcliffe Cardiology
@radcliffeCARDIO 💡 What turns an innovative idea into a medtech product that truly improves care? 📺 @WomenAs1 #CLIMB2026 presents Kit Yee Au-Yeung on building enduring, useful healthcare technology. 🧠 Start with the unmet need ⚠️ De-risk the technology, market and team 🔄 Test assumptions, htt 📺 @WomenAs1 #CLIMB2026 presents Kit Yee Au-Yeung on building enduring, useful healthcare technology. 🧠 Start with the unmet need ⚠️ De-risk the technology, market and team 🔄 Te/t.co/a7kwZz9LLh
Radcliffe Cardiology
@radcliffeCARDIO 💡 What turns an innovative idea into a medtech product that truly improves care? 📺 @WomenAs1 #CLIMB2026 presents Kit Yee Au-Yeung on building enduring, useful healthcare technology. 🧠 Start with the unmet need ⚠️ De-risk the technology, market and team 🔄 Test assumptions, htt 📺 @WomenAs1 #CLIMB2026 presents Kit Yee Au-Yeung on building enduring, useful healthcare technology. 🧠 Start with the unmet need ⚠️ De-risk the technology, market and team 🔄 Te/t.co/a7kwZz9LLh
Tweeted
11-09-2026
Radcliffe Cardiology
@radcliffeCARDIO How would you approach complex patients with ATTR-CM? Join Prof Emer Joyce, Prof Francesco Cappelli and Prof Erwan Donal for a live, case-based roundtable. 1 December 2026 | 18:00 CEST | Register free: radc.life/DYlXvjZH This programme is supported by an unrestricted
Radcliffe Cardiology
@radcliffeCARDIO How would you approach complex patients with ATTR-CM? Join Prof Emer Joyce, Prof Francesco Cappelli and Prof Erwan Donal for a live, case-based roundtable. 1 December 2026 | 18:00 CEST | Register free: radc.life/DYlXvjZH This programme is supported by an unrestricted
Tweeted
11-09-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 New #CardioOnc Webinar | 'Pericarditis in Patients with Cancer'. ⏰ 14:00 GMT | 09:00 EST 📅 Thursday 12 November Don’t miss out on this discussion with Dr Mohammed Alomar, Dr Aleksander Bermudez-Perez, Dr Daniel Lenihan and Dr Joe Carver. Regisco/edncQ3SXqM
Radcliffe Cardiology
@radcliffeCARDIO 🚨 New #CardioOnc Webinar | 'Pericarditis in Patients with Cancer'. ⏰ 14:00 GMT | 09:00 EST 📅 Thursday 12 November Don’t miss out on this discussion with Dr Mohammed Alomar, Dr Aleksander Bermudez-Perez, Dr Daniel Lenihan and Dr Joe Carver. Regisco/edncQ3SXqM
Tweeted
11-09-2026
Radcliffe Cardiology
@radcliffeCARDIO What defines value in AF ablation beyond the procedure itself? Join us at RIO USA for a Medtronic-supported symposium exploring the clinical and operational value of the Sphere-9™ catheter and Affera™ mapping and ablation system. 📅 14 November | 9:00–10:00 AM EST Cyi7A2JnFf
Radcliffe Cardiology
@radcliffeCARDIO What defines value in AF ablation beyond the procedure itself? Join us at RIO USA for a Medtronic-supported symposium exploring the clinical and operational value of the Sphere-9™ catheter and Affera™ mapping and ablation system. 📅 14 November | 9:00–10:00 AM EST Cyi7A2JnFf
Uploaded
11-09-2026
AHA 26: RACE-CARS: Improving Cardiac Arrest Systems of Care
AHA 26: RACE-CARS: Improving Cardiac Arrest Systems of Care RACE-CARS evaluates whether a community- and health system-wi ...
Uploaded
11-09-2026
AHA 2026: RACE-CARS | Bystander CPR Improved, What Can We Learn About Survival? #cardiology #news
AHA 2026: RACE-CARS | Bystander CPR Improved, What Can We Learn About Survival? #cardiology #news Visit Radcliffe Cardiol ...
Tweeted
11-09-2026
Radcliffe Cardiology
@radcliffeCARDIO RACE-CARS at #AHA2026 Watch the discussion here: https://t.co/jdWBFmOiWc 👥 22,459 patients📍 60 counties 🫀 Favourable neurological survival: 9.0% vs 9.4% 🤲 Bystander CPR: 44.8% vs 42.3% Primary outcome not improved. Late-breaker host, Dr @hvanspall aks Proradc.life/3HuXlavc 👥 22,459 patients📍 60 counties 🫀 Favourable neurological survival: 9.0% vs 9.4% 🤲 Bystander CPR: 44.8% vs 42.3% Primary outcome not improved. Late-breaker host, Dr @hvanspall aks Prof @cbo/vRe0Ru0yy3
Radcliffe Cardiology
@radcliffeCARDIO RACE-CARS at #AHA2026 Watch the discussion here: https://t.co/jdWBFmOiWc 👥 22,459 patients📍 60 counties 🫀 Favourable neurological survival: 9.0% vs 9.4% 🤲 Bystander CPR: 44.8% vs 42.3% Primary outcome not improved. Late-breaker host, Dr @hvanspall aks Proradc.life/3HuXlavc 👥 22,459 patients📍 60 counties 🫀 Favourable neurological survival: 9.0% vs 9.4% 🤲 Bystander CPR: 44.8% vs 42.3% Primary outcome not improved. Late-breaker host, Dr @hvanspall aks Prof @cbo/vRe0Ru0yy3
Uploaded
11-08-2026
AHA 2026: Cardiovascular Risk Across the Female Life Course
AHA 2026: Cardiovascular Risk Across the Female Life Course Dr Emily Lau joins us to discuss how reproductive and hormona ...
Uploaded
11-08-2026
AHA 2026: Revisiting LDL-C, ApoB & Lp(a) in the 2026 Dyslipidemia Guidelines #cardiology
AHA 2026: Revisiting LDL-C, ApoB & Lp(a) in the 2026 Dyslipidemia Guidelines #cardiology Visit Radcliffe Cardiology: http ...
Uploaded
11-08-2026
AHA 26: Putting the New Dyslipidemia Guidelines Into Practice
AHA 26: Putting the New Dyslipidemia Guidelines Into Practice Samia Mora joins us to discuss the 2026 ACC/AHA Multisociet ...
Uploaded
11-08-2026
AHA 26: SUMMIT: Tirzepatide and Cardiac Remodelling in HFpEF
AHA 26: SUMMIT: Tirzepatide and Cardiac Remodelling in HFpEF What can cardiac magnetic resonance tell us about the effect ...
